Neurocrine Biosciences
NBIX
#1401
Rank
NZ$26.32 B
Marketcap
NZ$263.99
Share price
-1.27%
Change (1 day)
14.50%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Cost to borrow NBIX shares - Neurocrine Biosciences

Latest borrow fee for Neurocrine Biosciences (NBIX) shares on Interactive Brokers: 0.4731% (annualized)

Shares available to borrow: 2000000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Neurocrine Biosciences (NBIX) - cost to borrow in the last 7 days chart

Neurocrine Biosciences (NBIX) - number of shares available to borrow in the last 7 days

Neurocrine Biosciences (NBIX) - cost to borrow from 2025 to 2023

Neurocrine Biosciences (NBIX) - number of shares available to borrow from 2025 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
Repligen
RGEN
0.3137%0.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
0.3619%3.2 M๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
15.0913%0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
0.25%8.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
0.2844%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
0.2586%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
0.3137%0.2 M๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
29.7439%1.6 M๐Ÿ‡บ๐Ÿ‡ธ USA